Target intelligence / Profile preview

Normal vaginal microbiota

Molecular classification
Microbiome, Other
01

Overview

The normal vaginal microbiota is a dynamic ecosystem of microorganisms that plays a fundamental role in female reproductive health. In healthy individuals of reproductive age, the community is typically dominated by Lactobacillus species, which maintain an acidic environment (pH < 4.5) through the production of lactic acid, thereby inhibiting the colonization of pathogenic organisms (Ravel et al., 2011, PNAS). This microbial community serves as a primary defense mechanism against infections such as bacterial vaginosis, vulvovaginal candidiasis, and sexually transmitted diseases (Borges et al., 2014, Arch Gynecol Obstet). Dysbiosis, characterized by a decrease in Lactobacilli and an increase in anaerobic diversity, is associated with adverse outcomes including preterm birth and increased susceptibility to viral infections like HIV (Petrova et al., 2015, Trends Microbiol). Therapeutic targeting of the vaginal microbiota involves the use of antibiotics to eliminate pathogens or live biotherapeutic products (LBPs) to restore beneficial bacteria (Cohen et al., 2020, NEJM). Recent advancements include vaginal microbiota transplantation (VMT) for recalcitrant cases of dysbiosis, highlighting the microbiota's role as a complex, living therapeutic target (Lev-Sagie et al., 2019, Nat Med).

Other names
Vaginal microbiomeVaginal floraVaginal microfloraVaginal microbial community
02

Mechanism of action

Restoration of microbial homeostasis through competitive exclusion of pathogens, production of antimicrobial metabolites such as lactic acid and hydrogen peroxide, and modulation of the local mucosal immune environment (Borges et al., 2014, Arch Gynecol Obstet; Cohen et al., 2020, NEJM).

03

Biological functions

Immune responsePathogen defenseMetabolic regulationOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Transfer of antibiotic resistance genesIntroduction of opportunistic pathogensLocal inflammatory responseDisruption of ecological balance
06

Interacting drugs

Lactobacillus crispatus CTV-05 (LACTIN-V)

4 more in the full profile.

07

Biomarkers

Nugent scoreVaginal pHLactobacillus abundanceClue cellsAmsel criteria

Beyond the preview

Go deeper on Normal vaginal microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Normal vaginal microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call